Drugs / ethynylestradiol
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00428311 | Apr 2004 → Oct 2006 | polycystic ovary syndrome | Hospital Universitario Ramon y Cajal | Completed | No outcome recorded |
Also used as a comparator or background therapy in 2 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT00593294 Comparator | Jan 2006 → Sep 2007 | polycystic ovary syndrome | Federico II University | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT00842140 Background | Feb 2006 → Jan 2009 | polycystic ovary syndrome | University of Sao Paulo | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ethynylestradiol | “oral contraceptive (0,03mg ethynylestradiol and 2mg chlormadinone acetate)once a day for 12 months” NCT00842140 ↗ |
| Route | Oral | “treatment with an oral contraceptive containing 35 microg ethinyl-estradiol plus 2 mg cyproterone acetate” PMID 18997670 ↗ Nov 2008 |